Literature DB >> 3571333

Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy.

N J Galvin, P M Vance, V M Dixit, B Fink, W A Frazier.   

Abstract

Binding of thrombospondin (TSP) to types I-V collagen was examined by direct binding assays using 125I-TSP and by visualization of rotary-shadowed intermolecular complexes in the electron microscope. The binding of TSP was highest to type V collagen in the absence of Ca, while lower but significant levels of binding were observed to all other collagen types in the presence or absence of Ca. Unlike intact TSP, the trimeric collagen-binding domain of TSP composed of 70-kD chains showed no Ca dependence in its binding to type V collagen. Further evidence for binding of TSP to types I and III collagen was obtained by competition studies in which these soluble collagens effectively inhibited binding of 125I-TSP to immobilized type V collagen. The binding of TSP to type V collagen was inhibited by heparin and fucoidin, both high-affinity ligands of TSP's heparin-binding domain. mAb A6.1, which binds to the 70-kD domain of TSP, is also the best of a panel of anti-TSP mAbs at inhibiting the TSP-collagen interaction. Electron microscopy of rotary-shadowed replicas of TSP-collagen complexes revealed that all five types of collagen examined had a binding site for TSP at one end of the pepsinized, triple helical molecule. The specificity of this site was tested by examining the ability of BSA to form a complex with the end of the pepsinized collagens. Rotary-shadowed replicas revealed a low frequency of apparent BSA-collagen complexes, and histograms of these data showed no evidence for the preferential association of BSA with the end of the collagen molecules. In addition to the specific end site, type V collagen had an internal binding site for TSP located about two-thirds of the distance along the length of the collagen molecule from the end site. The internal binding site for TSP on type V collagen is apparently the site responsible for the higher affinity binding of TSP to that protein observed in direct binding assays. The trimeric 70-kD collagen-binding domain of TSP bound to the same sites on the collagens as did intact TSP.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3571333      PMCID: PMC2114473          DOI: 10.1083/jcb.104.5.1413

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  41 in total

1.  Isolation and characterization of a high molecular weight glycoprotein from human blood platelets.

Authors:  J W Lawler; H S Slayter; J E Coligan
Journal:  J Biol Chem       Date:  1978-12-10       Impact factor: 5.157

2.  Collagen fractionation: separation of native types I, II and III by differential precipitation.

Authors:  R L Trelstad; V M Catanese; D F Rubin
Journal:  Anal Biochem       Date:  1976-03       Impact factor: 3.365

3.  Collagen heterogeneity in human cartilage: identification of several new collagen chains.

Authors:  R E Burgeson; D W Hollister
Journal:  Biochem Biophys Res Commun       Date:  1979-04-27       Impact factor: 3.575

4.  A thrombin-sensitive protein of human platelet membranes.

Authors:  N L Baenziger; G N Brodie; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1971-01       Impact factor: 11.205

5.  Ca2+-mediated association of glycoprotein G (thrombinsensitive protein, thrombospondin) with human platelets.

Authors:  D R Phillips; L K Jennings; H R Prasanna
Journal:  J Biol Chem       Date:  1980-12-25       Impact factor: 5.157

6.  Structural basis for apparent heterogeneity of collagens in human basement membranes: type IV procollagen contains two distinct chains.

Authors:  E Crouch; H Sage; P Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

7.  Crystallographic studies of calmodulin and homologs.

Authors:  R H Kretsinger
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

8.  Assembly and processing of procollagen V (AB) in chick blood vessels and other tissues.

Authors:  L I Fessler; C A Kumamoto; M E Meis; J H Fessler
Journal:  J Biol Chem       Date:  1981-09-25       Impact factor: 5.157

9.  Human keratinocytes synthesize and secrete the extracellular matrix protein, thrombospondin.

Authors:  N E Wikner; V M Dixit; W A Frazier; R A Clark
Journal:  J Invest Dermatol       Date:  1987-02       Impact factor: 8.551

10.  Fetal membrane collagens: identification of two new collagen alpha chains.

Authors:  R E Burgeson; F A El Adli; I I Kaitila; D W Hollister
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

View more
  42 in total

1.  Thrombospondin expression in traumatized skeletal muscle. Correlation of appearance with post-trauma regeneration.

Authors:  S C Watkins; G W Lynch; L P Kane; H S Slayter
Journal:  Cell Tissue Res       Date:  1990-07       Impact factor: 5.249

2.  Immunoelectron-microscopic studies of human platelet thrombospondin, von Willebrand factor, and fibrinogen redistribution during clot formation.

Authors:  S C Watkins; V Raso; H S Slayter
Journal:  Histochem J       Date:  1990-09

Review 3.  Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes.

Authors:  J Des Parkin; James D San Antonio; Vadim Pedchenko; Billy Hudson; Shane T Jensen; Judy Savige
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

Review 4.  Structures of thrombospondins.

Authors:  C B Carlson; J Lawler; D F Mosher
Journal:  Cell Mol Life Sci       Date:  2008-03       Impact factor: 9.261

5.  Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins.

Authors:  F R Agbanyo; J J Sixma; P G de Groot; L R Languino; E F Plow
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

6.  Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain.

Authors:  Barbara Margosio; Marco Rusnati; Katiuscia Bonezzi; Blue-Leaf A Cordes; Douglas S Annis; Chiara Urbinati; Raffaella Giavazzi; Marco Presta; Domenico Ribatti; Deane F Mosher; Giulia Taraboletti
Journal:  Int J Biochem Cell Biol       Date:  2007-10-09       Impact factor: 5.085

7.  The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous Nephropathy.

Authors:  Larissa Seifert; Elion Hoxha; Anna M Eichhoff; Gunther Zahner; Silke Dehde; Linda Reinhard; Friedrich Koch-Nolte; Rolf A K Stahl; Nicola M Tomas
Journal:  J Am Soc Nephrol       Date:  2018-03-19       Impact factor: 10.121

8.  Defining elastic fiber interactions by molecular fishing: an affinity purification and mass spectrometry approach.

Authors:  Stuart A Cain; Amanda McGovern; Elaine Small; Lyle J Ward; Clair Baldock; Adrian Shuttleworth; Cay M Kielty
Journal:  Mol Cell Proteomics       Date:  2009-09-15       Impact factor: 5.911

9.  Thrombospondin co-localises with TGF beta and IGF-I in the extracellular matrix of human osteoblast-like cells and is modulated by 17 beta estradiol.

Authors:  M Slater; J Patava; R S Mason
Journal:  Experientia       Date:  1995-03-15

10.  The interaction of Thrombospondins with extracellular matrix proteins.

Authors:  Kemin Tan; Jack Lawler
Journal:  J Cell Commun Signal       Date:  2009-10-16       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.